|
1
|
Ferlay J; ISME: GLOBOCAN 2012: Estimated
Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
http://globocan.iarc.fr/Default.aspx.
IARC CancerBase; 2013
|
|
2
|
Flores A and Marrero JA: Emerging trends
in hepatocellular carcinoma: Focus on diagnosis and therapeutics.
Clin Med Insights Oncol. 8:71–76. 2014.PubMed/NCBI
|
|
3
|
Peck-Radosavljevic M: Drug therapy for
advanced-stage liver cancer. Liver Cancer. 3:125–131. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al SHARP Investigators Study Group: Sorafenib in advanced
hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gauthier A and Ho M: Role of sorafenib in
the treatment of advanced hepatocellular carcinoma: An update.
Hepatol Res. 43:147–154. 2013. View Article : Google Scholar :
|
|
6
|
Wilhelm SM, Carter C, Tang L, Wilkie D,
McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, et al:
BAY 43-9006 exhibits broad spectrum oral antitumor activity and
targets the RAF/MEK/ERK pathway and receptor tyrosine kinases
involved in tumor progression and angiogenesis. Cancer Res.
64:7099–7109. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Cao Y, Chen C, Zhang X, McNabola A,
Wilkie D, Wilhelm S, Lynch M and Carter C: Sorafenib blocks the
RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor
cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer
Res. 66:11851–11858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rahmani M, Davis EM, Bauer C, Dent P and
Grant S: Apoptosis induced by the kinase inhibitor BAY 43-9006 in
human leukemia cells involves down-regulation of Mcl-1 through
inhibition of translation. J Biol Chem. 280:35217–35227. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang WA, Groenendyk J and Michalak M:
Endoplasmic reticulum stress associated responses in cancer.
Biochim Biophys Acta. 1843:2143–2149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Zhang K and Li Z: Unfolded protein
response in cancer: The physician’s perspective. J Hematol Oncol.
4:82011. View Article : Google Scholar
|
|
11
|
Vandewynckel YP, Laukens D, Geerts A,
Bogaerts E, Paridaens A, Verhelst X, Janssens S, Heindryckx F and
Van Vlierberghe H: The paradox of the unfolded protein response in
cancer. Anticancer Res. 33:4683–4694. 2013.PubMed/NCBI
|
|
12
|
Zhang XD, Hersey P, Tay KH, Tseng H, Jiang
CC and Dong L: Adaptation to ER stress as a mechanism of resistance
of melanoma to treatment. Current Management of Malignant Melanoma.
Cao M: InTech, Rijeka; Croatia: 2011
|
|
13
|
Suh DH, Kim MK, Kim HS, Chung HH and Song
YS: Unfolded protein response to autophagy as a promising druggable
target for anticancer therapy. Ann NY Acad Sci. 1271:20–32. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gardner BM and Walter P: Unfolded proteins
are Ire1-activating ligands that directly induce the unfolded
protein response. Science. 333:1891–1894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schröder M and Kaufman RJ: ER stress and
the unfolded protein response. Mutat Res. 569:29–63. 2005.
View Article : Google Scholar
|
|
16
|
Han D, Lerner AG, Vande Walle L, Upton JP,
Xu W, Hagen A, Backes BJ, Oakes SA and Papa FR: IRE1alpha kinase
activation modes control alternate endoribonuclease outputs to
determine divergent cell fates. Cell. 138:562–575. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hassler J, Cao SS and Kaufman RJ: IRE1, a
double-edged sword in pre-miRNA slicing and cell death. Dev Cell.
23:921–923. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tirosh B, Iwakoshi NN, Glimcher LH and
Ploegh HL: Rapid turnover of unspliced Xbp-1 as a factor that
modulates the unfolded protein response. J Biol Chem.
281:5852–5860. 2006. View Article : Google Scholar
|
|
19
|
Yoshida H, Matsui T, Yamamoto A, Okada T
and Mori K: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in
response to ER stress to produce a highly active transcription
factor. Cell. 107:881–891. 2001. View Article : Google Scholar
|
|
20
|
Maurel M, Chevet E, Tavernier J and Gerlo
S: Getting RIDD of RNA: IRE1 in cell fate regulation. Trends
Biochem Sci. 39:245–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chitnis N, Pytel D and Diehl JA:
UPR-inducible miRNAs contribute to stressful situations. Trends
Biochem Sci. 38:447–452. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin JH, Li H, Yasumura D, Cohen HR, Zhang
C, Panning B, Shokat KM, Lavail MM and Walter P: IRE1 signaling
affects cell fate during the unfolded protein response. Science.
318:944–949. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ron D, Chen CH, Caldwell J, Jamieson L,
Orr E and Mochly-Rosen D: Cloning of an intracellular receptor for
protein kinase C: A homolog of the beta subunit of G proteins. Proc
Natl Acad Sci USA. 91:839–843. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Adams DR, Ron D and Kiely PA: RACK1, A
multifaceted scaffolding protein: Structure and function. Cell
Commun Signal. 9:222011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma J, Wu R, Zhang Q, Wu JB, Lou J, Zheng
Z, Ding JQ and Yuan Z: DJ-1 interacts with RACK1 and protects
neurons from oxidative-stress-induced apoptosis. Biochem J.
462:489–497. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McCahill A, Warwicker J, Bolger GB,
Houslay MD and Yarwood SJ: The RACK1 scaffold protein: A dynamic
cog in cell response mechanisms. Mol Pharmacol. 62:1261–1273. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu J, Meng J, Du Y, Huang Y, Jin Y, Zhang
J, Wang B, Zhang Y, Sun M and Tang J: RACK1 promotes the
proliferation, migration and invasion capacity of mouse
hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1
signaling pathway. Biomed Pharmacother. 67:313–319. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao XX, Xu JD, Liu XL, Xu JW, Wang WJ, Li
QQ, Chen Q, Xu ZD and Liu XP: RACK1: A superior independent
predictor for poor clinical outcome in breast cancer. Int J Cancer.
127:1172–1179. 2010. View Article : Google Scholar
|
|
29
|
Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang
W, Xie J, Guo L, Zhou L, Yun X, et al: Ribosomal RACK1 promotes
chemoresistance and growth in human hepatocellular carcinoma. J
Clin Invest. 122:2554–2566. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito
H and Takekawa M: Formation of stress granules inhibits apoptosis
by suppressing stress-responsive MAPK pathways. Nat Cell Biol.
10:1324–1332. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiu Y, Mao T, Zhang Y, Shao M, You J, Ding
Q, Chen Y, Wu D, Xie D, Lin X, et al: A crucial role for RACK1 in
the regulation of glucose-stimulated IRE1alpha activation in
pancreatic beta cells. Sci Signal. 3:ra72010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liver Cancer Study Group of Japan: The
General Rules for the Clinical and Pathological Study of Primary
Liver Cancer. 2nd English edition. Kanehara & Co, Ltd; Tokyo:
pp. 13–14. 2003
|
|
33
|
Rojas R, Segovia C, Trombert AN, Santander
J and Manque P: The effect of tunicamycin on the glucose uptake,
growth, and cellular adhesion in the protozoan parasite Crithidia
fasciculata. Curr Microbiol. 69:541–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y and Brandizzi F: IRE1: ER stress
sensor and cell fate executor. Trends Cell Biol. 23:547–555. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Zhang K and Li Z: Unfolded protein
response in cancer: The physician’s perspective. J Hematol Oncol.
4:82011. View Article : Google Scholar
|
|
36
|
Fujimoto T, Onda M, Nagai H, Nagahata T,
Ogawa K and Emi M: Upregulation and overexpression of human X-box
binding protein 1 (hXBP-1) gene in primary breast cancers. Breast
Cancer. 10:301–306. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shuda M, Kondoh N, Imazeki N, Tanaka K,
Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, et al:
Activation of the ATF6, XBP1 and grp78 genes in human
hepatocellular carcinoma: A possible involvement of the ER stress
pathway in hepatocarcinogenesis. J Hepatol. 38:605–614. 2003.
View Article : Google Scholar : PubMed/NCBI
|
